Immediate colposcopy or cytological surveillance for women with mild dyskaryosis: a cost effectiveness analysis

Background The aim of the study was to compare the cost effectiveness of immediate diagnosis and treatment of mild dyskaryosis compared with the usual policy of cytological surveillance. Methods A cost effectiveness analysis was carried out alongside a randomized clinical trial, Results Immediate diagnosis and treatment increased total costs by 50 per cent from pound 54.42 per treated woman [95 per cent confidence interval (CI) pound 48.85-pound 59.98] in the surveillance group to pound 82.02 per woman in the immediate diagnosis and treatment group with an incremental cost of pound 27.60 (95 per cent CI pound 22.04-pound 33.17), However, the number of cases of CIN III detected increased by 69 per cent for the policy of immediate diagnosis and treatment, This led to an average cost effectiveness ratio of pound 180.18 for the immediate diagnosis and treatment group and pound 199.94 per case of CIN III detected for the surveillance group, with a marginal cost effectiveness ratio of pound 148.22 (95 per cent CI pound 94.01-pound 309.33) for the immediate diagnosis and treatment group, Conclusion Immediate diagnosis and treatment increases the total cost of managing mildly dyskaryotic smears but this increased cost is offset by a sharp increase in the number of cases of CIN III detected.